Brief: Bellus Health Announces Clearance Of U.S. IND For BLU-5937 Phase 2 Study

BELLUS Health

03/04/2019 12:20

April 3 (Reuters) - BELLUS Health Inc  BLU.TO :
    * BELLUS HEALTH ANNOUNCES CLEARANCE OF U.S. IND FOR BLU-5937
PHASE
2 STUDY IN CHRONIC COUGH PATIENTS
    * BELLUS HEALTH INC - PHASE 2 STUDY FOR POTENTIAL
BEST-IN-CLASS
THERAPEUTIC FOR REFRACTORY CHRONIC COUGH PATIENTS EXPECTED TO
START IN MID-2019
    * BELLUS HEALTH - EXPECTS TOP-LINE RESULTS FOR CLINICAL
PHASE 2
STUDY FOR BLU-5937 IN CHRONIC COUGH PATIENT IN MID-2020

Source text for Eikon:  ID:nCNWwgJLGa 
Further company coverage:  BLU.TO 

 ((Reuters.Briefs@thomsonreuters.com;))